CLICK HERE TO ORDER NOW: https://tinyurl.com/MY-BEST-CBD
Check out more
Best CBD Oil 2019 - CTFO 10X PURE Is The Best CBD Oil
CTFO is a brand you can trust. You may download all 3rd party lab tests and our scientific data right from our main page. Our products are FDA: GMP Certified, organic, non-GMO, and pesticide free. Our farms are USDA regulated.
While many companies fight over who has the purest and highest concentration of CBD and which is the best CBD Oil brands, CTFO is one step ahead of the pack. We dramatically improved the delivery system of getting CBD into your body and past the liver and kidneys!
Come discover why CTFO 10X Pure is the best CBD Oil for sale that delivers more of the vital cannabinoids into your body to help promote homeostasis. 10X Pure is the gold standard for helping promote a healthy endocannabinoid system. This is the system that keeps your body in balance and helps promote healing and optimized function.
In anticipation of record data usage by the tens of thousands of visitors to this year’s national political conventions, Verizon has made significant enhancements to its network in the host cities and convention facilities.
“We know sharing the convention experience is important for visitors to Cleveland and Philadelphia so we have invested millions of dollars and worked for several years on upgrading our networks and adding capacity for these events,” said Lynn Ramsey, Vice President Network Operations – Verizon.
Enhancing the network in Cleveland, Ohio
When the Republican National Convention (RNC) arrives in Cleveland July 18-21, Verizon will have completed improvements to the city’s #1 overall network as rated by RootMetrics* in a recent Metro Rootscore® report.
To view the multimedia release go to:
http://www.multivu.com/players/English/7814951-verizon-rnc-dnc-network/
The sixth annual Productive Innovation Index released by IDEA Pharma today, which ranks biopharmaceutical companies by their ability to successfully bring innovations to market, sees Johnson & Johnson top the industry for the fourth year running.
The Productive Innovation Index measures, scores and celebrates a company’s ability to deliver innovation to patients, by objectively evaluating performance data based on a rolling five year period (2010-2015), and operates on the premise: if you gave the same molecule to two different companies in early phase, which would make the best of it?
The success of the Janssen Pharmaceutical Companies of Johnson & Johnson and its consolidation of 1st place across the past four years’ rankings is driven largely by innovations in the field of oncology, immunology, neuroscience and cardiovascular/metabolism. Notable performers include Zytiga® (prostate cancer), Imbruvica® (chronic lymphocytic leukemia and mantle cell lymphoma (co-developed and co-marketed with Pharmacyclics, an AbbVie company)), Simponi®/Simponi Aria® (rheumatoid arthritis), Stelara® (psoriasis and psoriatic arthritis), Invega Sustenna® and Invega Trinza® (schizophrenia).
To view the multimedia release go to:
http://www.multivu.com/players/uk/7770851-johnson-and-johnson-tops-idea-pharma/
Professor Lionel Tarassenko, CBE, Head of Engineering at the University of Oxford and Fellow of the Royal Academy of Engineering and the Academy of Medical Sciences, has joined a panel of internationally recognised experts for the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain.
As the worlds of science and technology come together, the 2015 Astellas Innovation Debate, organised and funded by Astellas, will discuss recent breakthroughs in genetic medicine and smart technology, and what they mean for our health.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7432051-lionel-tarassenko-astellas-debate/
New data from a school asthma management program, “Building Bridges for Asthma Care,” presented today at the American Thoracic Society 2015 International Conference, show a significant decrease in school absenteeism among children with asthma from inner-city schools who were enrolled in the program. Absences dropped 11.75 percent among children enrolled in Building Bridges, compared to an increase of 8.48 percent in children with asthma not in the program.
“Building Bridges for Asthma Care” is a school-based program designed to empower nurses in participating elementary schools to ensure that asthmatic children are identified and provided care according to the National Institute of Health’s clinical treatment guidelines. The objectives of the program are addressing the risk of health disparities and asthma-related absenteeism, as well as its related impact on academic achievement for inner city students.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7506851-gsk-building-bridges-for-asthma-care/
https://youtu.be/dHE5O2GlGN8 British Telecom company TalkTalk’s October 2015 data breach was only one of many hitting consumers and the corporate world recently – Ashley Madison and Sony come to mind – but the lessons apply to every company, big and small. Here are three takeaways from the TalkTalk data breach – and the three big losses that affect any business after a cyber attack.
Industry leaders attending the first Smart China Expo (SCE 2018) in China’s western city of Chongqing have articulated a new vision for how the world’s digital economy will evolve at the event’s Global Digital Economy Summit, a forum that brought together 650 participants under the theme “New Digital Economy, New Growth Engine.” Speakers projected a future in which Big Data reshapes the way businesses and governments operate, cooperate, and compete.
New forces being unleashed by current innovations threaten to disrupt the existing economic growth models of many industries, as digital information will rise to the same status as land and capital as a key element of productivity. Meanwhile, governments around the world are building “smart infrastructure” as they seek to use technology to upgrade power grids, railways, ports and toll roads, and seek to integrate everything. Big Data technology also helps build “smart cities,” boost consumption, and improve social welfare programs ranging from education to philanthropy to healthcare.
To view the multimedia release go to:
https://www.multivu.com/players/English/8389751-smart-china-expo-sce-2018/
Personalised Medicine is the future of cancer treatment, but it presents major challenges for doctors and health services, the President of the European Society of Medical Oncology has said. Professor Rolf Stahel was speaking ahead of the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7430351-professor-rolf-stahel-astellas-debate/
A new test program by the Insurance Institute for Highway Safety (IIHS) rates the performance of front crash prevention systems to help consumers decide which features to consider and encourage automakers to speed adoption of the technology. The rating system is based on research by the Highway Loss Data Institute (HLDI) indicating that forward collision warning and automatic braking systems are helping drivers avoid front-to-rear crashes.
Data released today by the Association of Global Automakers (Global Automakers) demonstrates that their members’ presence in the U.S. continues to grow.
“With $46 billion invested into U.S. operations, our members are an integral part of the U.S. automobile industry,” said Michael J. Stanton, president and CEO of Global Automakers. “They are providing jobs for Americans and an essential part of the country’s manufacturing base.”
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62780-global-automakers-new-data-showcases-u-s-economic-impact
Today, Novo Nordisk announced new phase 3 interim data from its guardianTM2 trial for its recombinant coagulation factor VIII (rFVIII) product NovoEight® (turoctocog alfa), the first new rFVIII molecule in over a decade, which shows that it provides long-term reduction from bleeding in people with haemophilia A when used as a preventative treatment.1 The results were presented at the World Federation of Haemophilia (WFH) World Congress and support findings from other studies within the guardianTM clinical programme that found NovoEight® demonstrated good efficacy in preventing and treating bleeds without inhibitor development in previously treated patients.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/71400529-novoeight-reduction-of-bleeding-haemophilia-a
Advanced technology has the power to transform healthcare, a world leader in the field of genomicsDr Leroy Hood, has said ahead of the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7430051-dr-leroy-hood-astellas-debate/
